Medical Advocates
HCV Infection/Disease
  Cardiovascular Disorders
 
General Reports
 Atherosclerosis
 Heart Disease
 Polyarteritis Nodosa
 Vasculitis





 		  
HCV Extrahepatic Disorders Main New/Newsworthy    Home Page    
Last Update:  January 26, 2015
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
                          
         Journal Papers, Abstracts, and Commentaries
 
 
Associations of chronic hepatitis C with metabolic and cardiac outcomes.
 Younossi ZM, Stepanova M, Nader F,  et al
 Aliment Pharmacol Ther. 2013 Feb 5. 
Abstract

Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.
 Kakinami L, Block RC, Adams MJ,  et al
Int J Clin Pract. 2013 Jan;67(1):6-13.
Abstract

Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature.
 Roed T, Lebech AM, Kjaer A, Weis N.
Clin Physiol Funct Imaging. 2012 Nov;32(6):421-30
 Abstract

Myocardial injury in patients with chronic hepatitis C infection.
Maruyama S, Koda M, Oyake N, et al
 J Hepatol. 2012 Aug 10.
 Abstract

Effects of Hepatitis C virus on cardiovascular risk in infected patients: A comparative study.
Oliveira CP, Kappel CR, Siqueira ER, et al
 Int J Cardiol. 2011 Jul 22.
 Abstract
 
                          
Atherosclerosis
 
         Journal Papers, Abstracts, and Commentaries
 
 
Insulin-resistance HCV infection-related affects vascular stiffness in normotensives.
Perticone M, Maio R, Tassone EJ, et al
 Atherosclerosis. 2014 Nov 29;238(1):108-112.
 Abstract

FULL-TEXT ARTICLE
 Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis.
 Huang H, Kang R, Zhao Z.
PLoS One. 2014 Sep 3;9(9):e106376.
Paper

FULL-TEXT ARTICLE
 Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms.
 Adinolfi LE, Zampino R, Restivo L,  et al
World J Gastroenterol. 2014 Apr 7;20(13):3410-3417
 Paper

Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.
Adinolfi LE, Restivo L, Zampino R, et al
Atherosclerosis. 2012 Feb
Abstract

Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic
risk factors.
 Mostafa A, Mohamed MK, Saeed M, et al
Gut. 2010 Jun 28
 Abstract

The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance
in Patients with HIV-Associated Lipoatrophy and Hypoleptinemia.
 Mulligan K, Khatami H, Schwarz JM, et al
J Clin Endocrinol Metab. 2009 Jan 27.
 Abstract

Metabolic disorders and chronic HIV and HCV infection.
Slama L, Le Camus C, Serfaty L, et al
 Diabetes Metab. 2008 Nov 27.
Abstract
Heart Disease
                          
         Journal Papers, Abstracts, and Commentaries
 
 
Cardiovascular Disease and Hepatitis C Virus Infection: An Irrelevant Statement or a Hot Relationship?
Katsi V, Felekos I, Skevofilax S, et al
Cardiol Rev. 2014 Jun 12
 Abstract

The Risk of Incident Coronary Heart Disease Among Veterans With and
Without HIV and Hepatitis C.
Freiberg MS, Chang CC, Skanderson M, et al
 Circ Cardiovasc Qual Outcomes. 2011 Jun 28
 Abstract

Hepatitis C Virus Infection and the Risk of Coronary Disease.
 Butt AA, Xiaoqiang W, Budoff M, et al 
Clin Infect Dis. 2009 Jun 9
 Abstract

Hepatitis C associated cardiomyopathy: Potential pathogenic mechanisms and
clinical implications.
 Sanchez MJ, Bergasa NV
Med Sci Monit. 2008 May;14(5):RA55-63.
 Abstract
Polyarteritis Nodosa
                          
         Journal Papers, Abstracts, and Commentaries
 
 
Polyarteritis nodosa and cryoglobulinemic glomerulonephritis related to chronic hepatitis C.
 Canada R, Chaudry S, Gaber L, et al  
Am J Med Sci. 2006 Jun;331(6):329-33.
 Abstract
 
Vasculitis
                          
         Journal Papers, Abstracts, and Commentaries
 
 
Presentation and Prognosis of Cardiac Involvement in Hepatitis C Virus-Related Vasculitis.
Terrier B, Karras A, Cluzel P,  et al
Am J Cardiol. 2012 Oct 29.
 Abstract

Renal involvement in HCV-related vasculitis.
 Terrier B, Cacoub P. 
Clin Res Hepatol Gastroenterol. 2013 Apr 2.
 Abstract

FULL-TEXT ARTICLE
 Efficacy and safety of rituximab in the treatment of vasculitic leg ulcers associated with hepatitis C virus infection.
 Bonilla-Abadía F, Echeverri AF,  et al
 Case Report Rheumatol. 2012;2012:923897.
 Paper

The Place of Immunotherapy in the Management of HCV-Induced Vasculitis: An Update.
 Chiche L, Bataille S, Kaplanski G, Jourde N.
 Clin Dev Immunol. 2012;2012:315167. .
 Abstract

Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy.
St Clair EW.
 Arthritis Rheum. 2011 Dec 6.
 Abstract

Systemic Vasculitis in Patients with Hepatitis C Virus Infection with and without
Detectable Mixed Cryoglobulinemia.
 Terrier B, Sène D, Dechartres A, et al
J Rheumatol. 2010 Oct 15.
 Abstract

A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic
vasculitis receiving intravenous methylprednisolone and cyclophosphamide.
 Shahin AA, El Desouky SM, Zayed HS.
Clin Rheumatol. 2010 Oct 6.
 Abstract

Surrogate markers of B cell non-Hodgkin’s lymphoma in patients with hepatitis C
virus-related cryoglobulinaemia vasculitis.
 Geri G, Terrier B, Semoun O, et al
Ann Rheum Dis. 2010 Sep 27.
 Abstract
 

HCV Extrahepatic Disorders Main New/Newsworthy    Home Page    

HCV Cardiovascular Disorders